CUV 1.61% $14.68 clinuvel pharmaceuticals limited

I guess we will see if the expert opinion is positive by...

  1. 594 Posts.
    lightbulb Created with Sketch. 281
    I guess we will see if the expert opinion is positive by Clinuvel's next steps. My guess is that further trials will not be progressed as there is not enough of an efficacy signal to justify further investment. Clinuvel will not announce this. They will instead announce that progress will be determined following discussions with regulators and securing IP which will always be about to happen. VP ( 4 years), vitiligo (10 years), 6th indication (18 months), OTC (3 years) all waiting for something.
    Last edited by cuv101: 06/05/22
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.